Deal Announcements

GraftCath Collects $12 Million Series D Round

Thursday, February 21, 2008 5:49:00 AM PDT | VentureDeal staff

Eden Prairie, MN -- Medical device company GraftCath, Inc. has received $12 million in series D venture capital investment, according to a report in PE Hub.

GraftCath is developing femoral vascular closure procedure technologies and medical devices.

Affinity Capital lead the round, which included fellow new investor Ascension Health Ventures and existing investors Cutlass Capital, Sapient Capital and Three Arch Partners.

The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1